Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
national top stories
boston
boston blog main
boston top stories
enzyme
gene editing
san francisco blog main
san francisco top stories
agios therapeutics
base editing
biopharma
branden moriarty
broad institute
cas13
clinical study
crispr therapeutics
crispr-cas9
data
david liu
deals
disease
dna
duchenne
editas medicine
editor
editr
europe blog main
europe top stories
feng zhang
gag
genome editing
harvard university
hunter syndrome
ids
intellia therapeutics
john evans
keith joung
What
gene
3
×
medicine
3
×
therapeutics
3
×
editing
approval
beam
benefit
betting
billion
biopharma
cas
crispr
deal
duchenne
editas
editor
fda
founders
going
gotten
harvard
historic
humans
isn't
jump
landmark
little
mass
morning
nasdaq
phase
precise
puts
recently
reported
reports
results
rna
roche
sangamo
Language
unset
Current search:
therapeutics
×
medicine
×
gene
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M
